SOURCE: Antisoma plc

September 16, 2009 02:07 ET

Antisoma to present at the Bank of America Merrill Lynch Global Healthcare Conference in London

LONDON and CAMBRIDGE, MA--(Marketwire - September 16, 2009) -

Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present an overview of the Company's strategy, programmes and prospects at the Bank of America Merrill Lynch Global Healthcare conference in London, today at 09:50 BST/04:50 EDT.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Daniel Elger
VP, Marketing and Communications
Antisoma plc
+44 (0)7909 915 068

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Contact Information